BenjaminRobertLewisMD

Psychiatry • Salt Lake City, UT

Physician

Join to view full profile

Dr. Lewis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lewis' full profile

Already have an account?

Office
University of Utah Neuropsychiatric Institute
501 Chipeta Way
Salt Lake City, UT 84105

Summary

I am a board certified psychiatrist who focuses on adult psychiatry, ketamine-assisted psychotherapy, and clinical research with psychedelic-assisted therapies. I have completed training in psychedelic-assisted therapies through the California Institute of Integral Studies (CIIS), the Multidisciplinary Association for Psychedelic Studies (MAPS), and the Psychedelic Research and Training Institute (PRATI). I am the principal investigator on 3 current clinical trials on psychedelic-assisted therapy and am interested primarily in group format interventions as well as combinations of psychedelic medicine and mindfulness interventions. I am also the medical director of the HMHI Ketamine-Assisted Psychotherapy Clinic.

Benjamin Lewis: Could psychedelics help patients in therapy?

Could psychedelics aid the therapy process? | Dr. Benjamin Lewis | TEDxSaltLakeC

TEDx talk September 2023.

HMHI Ketamine-Assisted Psychotherapy (KAP) Clinic

HMHI offers ketamine-assisted psychotherapy for depression at our Park City Behavioral Health Clinic.

Education & Training

University of Utah HealthChief Residency, Psychiatry, 2011 - 2012
University of Utah HealthResidency, Psychiatry, 2008 - 2012
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2008
Harvard UniversityBA, English, Magna Cum Laude, 1996 - 2001

Certifications & Licensure

UT State Medical License 2009 - 2026
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers Start of enrollment: 2023 Oct 13
Recruiting
Early Phase 1
Roles: Principal Investigator, Contact
PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout Start of enrollment: 2023 Jan 02
Recruiting
Early Phase 1
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

7 citations
HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.
Benjamin R Lewis, Eric L Garland, Kevin Byrne, Tyler Durns, John Hendrick
Journal of Pain and Symptom Management. 2023-09-01
'What does epistemic injustice add? A response to Grim and Aftab'.
Brent M Kious, Benjamin R Lewis, Scott Y H Kim
Psychological Medicine. 2023-09-01
A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
Benjamin R Lewis, Kevin Byrne
Focus. 2023-07-01

Journal Articles

Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)
Lewis, Benjamin R.; Byrne, Kevin; Beck, Anna, Journal of anesthesiology and pain therapy, 10/3/2023
HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.
Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking P, J Pain Symptom Management, 9/1/2023
A Review of MDMA-Assisted Therapy for Post-Traumatic Stress Disorder (PTSD)
Lewis, Benjamin R; Byrne, Kevin, FOCUS: The Journal of Lifelong Learning in Psychiatry, 7/14/2023
In Naturalistic Psychedelic Use, Group Use is Common and Acceptable
Byrne K, Lindsay S, Baker N, Schmutz C, Lewis B, J Psychedelic Stud, 6/19/2023
What does epistemic injustice add? A response to Grim and Aftab
Kious BM, Lewis BR, Kim SYH, Psychological Medicine, 5/29/2023
Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial
Lewis BR, Hendrick J, Byrne K, Garland E, Thielking P, Beck A, J. Psychedelic Studies, 1/18/2023
Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers
Kious BM, Schwartz Z, Lewis BR, Journal of Psychopharmacology, 11/15/2022
Epistemic injustice and the psychiatrist
Kious BM, Lewis BR, Kim SYH, Psychological Medicine, 1/5/2022
Is MDD the right target for early-stage psychedelic-assisted therapy trials?
Lewis BR, Byrne K, J. Psychedelic Studies, 9/14/2021
Some aspects of containment matter
Lewis BR, Philosophy, Psychiatry, and Psychology, 9/10/2021
Update on Psychedelic Therapies for Mental Health
Lewis BR, Byrne K, Clinical and Forensic Toxicology News, 3/1/2021
Classifying psychiatric disorders as communicable diseases.
Kious BM, Lewis BR, Lancet Psychiatry, 1/1/2019
Shame
Case GA, Pippitt KA, Lewis BR, Perspectives in Medical Education, 6/1/2018
The Drugs Didn't Mix: On the Overvaluation of Misvaluation
Lewis BR, Philosophy, Psychiatry, and Psychology, 6/1/2015
Diseases, patients and the epistemology of practice: mapping the borders of health, medicine and care.
Loughlin M, Bluhm R, Fuller J, Buetow S, Borgerson K, Lewis BR, Kious BM, J Evaluation in Clinical Practice, 6/1/2015
On the Overvaluation of Misvaluation
Lewis BR, Philosophy, Psychiatry, Psychology, 1/1/2015
Join now to see all

Books/Book Chapters

Encyclopedia of Clinical Psychology
Chapter: The organic-functional distinction
Lewis BR, Kious BM2015